CTLA4 and neoplasm: Targeting with CTLA-4, PD-1 or PD-L1 antibodies reverses the exhaustion of cytotoxic T lymphocytes thus leading to the elimination of tumor cells via the re-induction of the “natural” function of the T cell population.